Activest Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Activest Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298	Buy	+4	New	+$280	﹤0.01%	1122

Other funds holding BBIO

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Activest Wealth Management's BBIO Position: Q2 2026 in Review

Activest Wealth Management opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 4 shares worth $298. The stake represents ﹤0.01% of the portfolio and ranks #1122 among its holdings.

90 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Activest Wealth Management held 4 shares of BridgeBio Pharma worth $298 as of Q2 2026.
BridgeBio Pharma was a new Activest Wealth Management position in Q2 2026.
BridgeBio Pharma made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1122 holding.
90 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.